Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemia.
- Resource Type
- Academic Journal
- Source
Supportive Care in Cancer (SUPPORT CARE CANCER), Sep2021; 29(9): 5323-5327. (5p)- Subject
- Language
- English
- ISSN
- 0941-4355